Business Description
Cardiff Oncology is a San Diego-based company focused on developing new cancer treatments, with its primary effort centered on a drug called Onvansertib ? a pill designed to target a specific protein involved in tumor growth. The drug is being tested across several hard-to-treat cancers, including colorectal cancer with certain genetic mutations, pancreatic cancer, lung cancer, breast cancer, and a form of leukemia. Founded in 1999, the company has built its pipeline around combination treatment approaches, pairing Onvansertib with established therapies to improve outcomes for patients who have limited options.
